mRNA COVID-19 疫苗接种后伴 Graves 病病史患者出现胫前黏液水肿和甲状腺眼病。
Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.
机构信息
Consultation multidisciplinaire des orbitopathies, Service d'endocrinologie et maladies métaboliques, pôle cardiovasculaire et métabolique, CHU de Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France.
Consultation multidisciplinaire des orbitopathies, Service d'endocrinologie et maladies métaboliques, pôle cardiovasculaire et métabolique, CHU de Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France.
出版信息
Ann Endocrinol (Paris). 2024 Apr;85(2):100-103. doi: 10.1016/j.ando.2023.10.004. Epub 2023 Oct 20.
A 70-year-old female had a history of thyroid surgery for benign nodules and Graves' disease. Following mRNA COVID-19 vaccination, she presented Graves' orbitopathy and pretibial myxedema. Symptoms of thyroid eye disease and thyroid dermopathy improved after 500-mg methylprednisolone infusions.
一位 70 岁女性因良性结节和 Graves 病行甲状腺手术。接种 mRNA COVID-19 疫苗后，她出现 Graves 眼病和胫前黏液水肿。经 500mg 甲泼尼龙输注后，甲状腺眼病和甲状腺皮肤病的症状得到改善。
Zotero 插件